Vascular Biology and Metabolism (VAM)

< Back

Overview

The Vascular Biology and Metabolism (VAM) area was created to enable a comprehensive, cooperative and multidisciplinary approach to research, development and transference of solutions for a group of diseases that are the leading cause of morbidity and mortality in the world: cardio- and neurovascular diseases, diabetes-metabolic syndrome and kidney failure.

This area also includes a group focused on Ophtalmology research and the Medical Molecular Imaging multidisciplinary group.

Publications

230
total
1,274.219
impact factor
5.542
average impact factor

Director: David García-Dorado García

group-team team group-zoom zoom group-download download

Research Areas

During 2017, our group has taken important steps to enhance its activity in high level scientific cooperative networks. We have had a prominent role in the foundation of the cardiovascular area of CIBER where we coordinate 2 research lines: myocardial ischemia-reperfusion and aorta diseases. The IP is the coordinator of one of the longitudinal CIBERCV programs and a member of the Steering Committee of research plans. Also, we have joined the COST EU-CARDIOPROTECTION-H2020, which includes principle European groups in myocardial protection against reperfusion damage. New researchers have joined our group through competitive calls such as Río Hortega, PFIS and FIS. In addition, we have completed the recruitment of patients for the PRECISED Study which is an integrated project of excellence of ISCIII on cardiovascular risk in diabetic patients in which the areas of vascular biology and metabolism of VHIR participate. Lastly, many articles have been published in major research journals.

VHIR Annual Report 2017

© FIR-HUVH Fundació Institut de Recerca Hospital Universitari Vall d’Hebron 2017 | Developed by: ondeuev